Simultaneous Determination of Two Components in Furazolidone, Indometacin and Cuscohygrinolis α-Acetylbenzoacetate Suppositories by HPLC with Dual Wavelength Detection
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3969/j.issn.1008-049X.2017.09.047
   		
        
        	
        		- VernacularTitle:HPLC双波长法同时测定美辛唑酮红古豆醇酯栓中的2种有效成分
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yi SONG
			        		
			        		;
		        		
		        		
		        		
			        		Fanjian KONG
			        		
			        		;
		        		
		        		
		        		
			        		Yinke LI
			        		
			        		;
		        		
		        		
		        		
			        		Quan WANG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		HPLC;
			        		
			        		
			        		
				        		Dual wavelength detection;
			        		
			        		
			        		
				        		Furazolidone;
			        		
			        		
			        		
				        		indometacin and cuscohygrinolis α-acetylbenzoacetate supposito-ries;
			        		
			        		
			        		
				        		Furazolidone;
			        		
			        		
			        		
				        		Indometacin
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			China Pharmacist
	            		
	            		 2017;20(9):1684-1686
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective:To establish an analytical method for the determination of furazolidone and indometacin in furazolidone, in-dometacin and cuscohygrinolis α-acetylbenzoacetate suppositories by HPLC. Methods: The separation was performed on a ZORBAX Extend-C18 (250 mm × 4. 6 mm,5μm) column. The mobile phase was acetonitrile and 0. 035 mol·L-1 potassium phosphate monobas-ic aqueous solution (adjusting pH to 3. 0 with acetic acid) with gradient elution. The flow rate was 1. 0 ml·min-1, and the detection wavelengths were set at 364 nm and 318 nm. The column temperature was 30℃ and the injection volume was 20 μl. Results:Under the selected chromatographic conditions, the two components showed good linearity within the range of 0.005-0.05 mg·ml-1(r=0. 9999). The limit of detection was 20 ng·ml-1 and 26 ng·ml-1, respectively. The limit of quantitation was 70 ng·ml-1 and 90 ng·ml-1, respectively. The average recovery was 99. 4%(RSD=0. 6%, n=9)and 99. 4%(RSD=0. 3%,n=9),respectively. Conclusion:The method is simple, rapid and specific, and the results are accurate and reliable. The method can be used for the de-termination of the two components in furazolidone, indometacin and cuscohygrinolis α-acetylbenzoacetate suppositories.